Novel bifidobacterium breve jkl2022 strain and method for producing conjugated linoleic acid using thereof

Abstract

The present invention relates to a Bifidobacterium breve JKL2022 strain capable of mass-producing natural conjugated linoleic acid (CLA), and a method for mass-producing conjugated linoleic acid using the same. The method of the present invention makes it possible to easily produce natural CLA in large quantities and high purity of functional CLA in a linoleic acid solution (50 mg/ml) using bacterial cells or cell-free extracts. The cell or cell-free extract of Bifidobacterium breve JKL2022 strain of the present invention, and the conjugated linoleic acid (CLA) produced thereby can be widely used in probiotic compositions, pharmaceutical compositions, health functional food compositions, feed additive compositions, and food additive compositions.

Dependencies are inferred from the claim text.